| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |